Intracoronary Bone Marrow–Derived Progenitor Cells in Acute Myocardial Infarction

Abstract

Intracoronary administration of BMC is associated with improved recovery of left ventricular contractile function in patients with acute myocardial infarction. Large-scale studies are warranted to examine the potential effects of progenitor-cell administration on morbidity and mortality.